HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Lionel Apetoh Selected Research

Calreticulin

1/2013Bleomycin exerts ambivalent antitumor immune effect by triggering both immunogenic cell death and proliferation of regulatory T cells.
9/2009Witch hunt against tumor cells enhanced by dendritic cells.
4/2008Immunogenicity of anthracyclines: moving towards more personalized medicine.
12/2007Ecto-calreticulin in immunogenic chemotherapy.
10/2007Molecular determinants of immunogenic cell death: surface exposure of calreticulin makes the difference.
9/2007Leveraging the immune system during chemotherapy: moving calreticulin to the cell surface converts apoptotic death from "silent" to immunogenic.
3/2007Immunogenic chemotherapy: discovery of a critical protein through proteomic analyses of tumor cells.
3/2007[Calreticulin dictates the immunogenicity of anti-cancer chemotherapy and radiotherapy].
1/2007Calreticulin exposure dictates the immunogenicity of cancer cell death.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Lionel Apetoh Research Topics

Disease

44Neoplasms (Cancer)
11/2015 - 02/2006
6Breast Neoplasms (Breast Cancer)
07/2011 - 09/2007
3Inflammation
08/2015 - 09/2010
3Autoimmune Diseases (Autoimmune Disease)
12/2011 - 06/2010
2Melanoma (Melanoma, Malignant)
01/2014 - 02/2013
2Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
05/2013 - 09/2010
2Residual Neoplasm
06/2008 - 10/2007
1Neoplasm Metastasis (Metastasis)
11/2015
1Colorectal Neoplasms (Colorectal Cancer)
11/2015
1Lymphopenia (Lymphocytopenia)
01/2014
1Hodgkin Disease (Hodgkin's Disease)
01/2013
1Testicular Neoplasms (Testicular Cancer)
01/2013
1Glioma (Gliomas)
04/2012
1Graft vs Host Disease (Graft-Versus-Host Disease)
09/2010
1Fibrosarcoma
06/2010
1Hypertension (High Blood Pressure)
02/2010
1Colonic Neoplasms (Colon Cancer)
11/2008
1Carcinoma (Carcinomatosis)
04/2008

Drug/Important Bio-Agent (IBA)

9CalreticulinIBA
01/2013 - 01/2007
7AnthracyclinesIBA
11/2015 - 09/2007
7HMGB1 Protein (HMG1)IBA
03/2014 - 09/2007
6AntigensIBA
02/2011 - 09/2007
5Fluorouracil (Carac)FDA LinkGeneric
03/2015 - 04/2010
5Toll-Like Receptor 4IBA
10/2008 - 09/2007
4Neoplasm Antigens (Tumor Antigens)IBA
01/2015 - 12/2007
4InterferonsIBA
03/2014 - 02/2006
3interleukin-21 (interleukin 21)IBA
02/2015 - 06/2010
3Cyclophosphamide (Cytoxan)FDA LinkGeneric
11/2013 - 11/2008
3Interleukin-10 (Interleukin 10)IBA
05/2013 - 09/2010
2CytokinesIBA
02/2015 - 12/2011
2Dacarbazine (DIC)FDA LinkGeneric
01/2014 - 02/2013
2LigandsIBA
02/2013 - 06/2011
2Interleukin-1 (Interleukin 1)IBA
01/2013 - 10/2009
2InterleukinsIBA
03/2011 - 06/2010
2oxaliplatin (Eloxatin)FDA LinkGeneric
03/2011 - 02/2010
2Interferon-gamma (Interferon, gamma)IBA
02/2010 - 10/2009
2Adenosine Triphosphate (ATP)IBA
02/2010 - 10/2009
1Formyl Peptide Receptors (Formyl Peptide Receptor)IBA
11/2015
1Interleukin-4 (Interleukin 4)IBA
08/2015
1Interleukin-5 (Interleukin 5)IBA
08/2015
1Interleukin-13IBA
08/2015
1pyrimidineIBA
03/2015
1Interleukin-9 (Interleukin 9)IBA
02/2015
1Biological Markers (Surrogate Marker)IBA
03/2014
1O-cyclopentyl-S-diethylaminoethyl methylphosphonothioateIBA
03/2014
1trastuzumab (Herceptin)FDA Link
03/2014
1AdenosineFDA LinkGeneric
03/2014
1Immunologic Factors (Immunomodulators)IBA
01/2014
1Anti-Bacterial Agents (Antibiotics)IBA
11/2013
1OxygenIBA
01/2013
1Transforming Growth Factor beta (TGF-beta)IBA
01/2013
1Cathepsin BIBA
01/2013
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2013
1bevacizumabFDA Link
04/2012
1Interleukin-6 (Interleukin 6)IBA
03/2012
1gemcitabineFDA Link
01/2012
1Interleukin-12 (IL 12)IBA
12/2011
1interleukin-22 (IL-22)IBA
03/2011
1Interleukin-17 (Interleukin 27)IBA
03/2011
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
03/2011
1MucinsIBA
09/2010
1Immunoglobulins (Immunoglobulin)IBA
09/2010
1Galectins (Galectin)IBA
08/2010
1Transcription Factors (Transcription Factor)IBA
06/2010
1Amiloride (Midamor)FDA LinkGeneric
02/2010
1Dichlorodiphenyldichloroethane (DDD)IBA
02/2010
1marenostrin (pyrin)IBA
10/2009
1Interleukin-1beta (Interleukin 1 beta)IBA
10/2009
1Purinergic Receptors (Receptors, Purine)IBA
10/2009
1CytotoxinsIBA
11/2008
1TNF-Related Apoptosis-Inducing LigandIBA
11/2008
1Interleukin-2 (IL2)IBA
05/2008
1imatinib (Gleevec)FDA Link
05/2008
1iodonitrotetrazolium (INT)IBA
05/2008
1Etoposide (VP 16)FDA LinkGeneric
01/2007
1Mitomycin (Mitomycin-C)FDA LinkGeneric
01/2007
1DNA (Deoxyribonucleic Acid)IBA
01/2007

Therapy/Procedure

25Drug Therapy (Chemotherapy)
11/2015 - 03/2007
14Radiotherapy
01/2015 - 03/2007
3Immunotherapy
01/2012 - 01/2008
2Aftercare (After-Treatment)
07/2011 - 03/2011
1Adjuvant Chemotherapy
11/2015
1Tissue Therapy (Cell Therapy)
02/2015
1Therapeutics
01/2012